Related Experiment Videos
Aspirin and prevention of myocardial infarction
1Department of Medicine, Medical College of Georgia, Augusta 30912-3104.
Insights
Low-dose aspirin (acetylsalicylic acid) may protect the heart by improving the prostacyclin-to-thromboxane ratio, potentially reducing cardiovascular deaths in conditions like unstable angina and myocardial infarction.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Aspirin (acetylsalicylic acid) is investigated for cardioprotective effects.
- Its mechanism involves modulating the prostacyclin-to-thromboxane ratio.
Purpose of the Study:
- To review aspirin's mechanism of action.
- To discuss aspirin's role in preventing myocardial infarction.
Main Methods:
- Literature review of basic science and clinical investigations.
- Analysis of aspirin's pharmacological effects.
Main Results:
- Low-dose aspirin appears to induce a favorable prostacyclin-to-thromboxane ratio.
- This ratio may reduce cardiovascular mortality in unstable angina and myocardial infarction.
Conclusions:
- Aspirin's cardioprotective effects are significant.
- Further research is needed to determine optimal aspirin dosage, frequency, and timing for preventing vaso-occlusive events.
Abstract:
Determining the cardioprotective effects of aspirin (acetylsalicylic acid) remains a focus for both basic science and clinical investigation. Although other contributors are probably present, the favorable prostacyclin-to-thromboxane ratio induced by low-dose aspirin appears beneficial for reducing cardiovascular mortality associated with unstable angina and myocardial infarction. The precise dosage, frequency and timing of aspirin's administration to reduce the incidence of vaso-occlusive events remains to be determined. This article reviews aspirin's mechanism of action and use for the prevention of myocardial infarction.